Patients with Philadelphia chromosome–positive CML in chronic phase will no longer be required to fast before taking nilotinib tablets.
Approval Alert | Nilotinib Tablets in Ph+ CML in Chronic Phase
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves SC Pembrolizumab Formulation in Solid Tumors
2
Cevostamab Post-CAR T-Cell Therapy is Safe in Heavily Pretreated Multiple Myeloma
3
BPd Maintenance Safe, Yields Responses in High-Risk Multiple Myeloma
4
Cevostamab Combo Shows Enduring Responses in R/R Multiple Myeloma
5
